CEFPIROME IN RESPIRATORY TRACT INFECTIONS

We carried out clinical studies on cefpirome (CPR), a new cephalosporin in respiratory tract infections and obtained the following results. Nine patients (six with pneumonia and one each with bronchopneumonia, diffuse panbronchiolitis and chronic bronchitis) were treated with 1.0 or 2.0 g doses of C...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 39; no. Supplement1; pp. 547 - 549
Main Authors OSHITANI, HIROSHI, MIURA, HIROSHI, INOUE, TAKASHI, KAWAHIRA, MASAHIDE, TAKEDA, HIROAKI, KOBAYASHI, HIROYUKI
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1991
Subjects
Cefpirome
Online AccessGet full text

Cover

More Information
Summary:We carried out clinical studies on cefpirome (CPR), a new cephalosporin in respiratory tract infections and obtained the following results. Nine patients (six with pneumonia and one each with bronchopneumonia, diffuse panbronchiolitis and chronic bronchitis) were treated with 1.0 or 2.0 g doses of CPR twice a day by i.v. drip infusion. The clinical response to CPR was excellent in 1, good in 5, poor in 2 and unknown in 1 patient. No side effects were observed. Laboratory findings revealed mild eosinophilia in one case, but this abnormality quickly disappeared. From our results, we consider that CPR would be useful for the treatment of respiratory tract infections.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.39.Supplement1_547